Morr M - Search Results

1

The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties.

Ebensen T, Schulze K, Riese P, Link C, Morr M, Guzmán CA. Ebensen T, et al. Among authors: morr m. Vaccine. 2007 Feb 9;25(8):1464-9. doi: 10.1016/j.vaccine.2006.10.033. Epub 2006 Nov 3. Vaccine. 2007. PMID: 17187906

2

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.

Ebensen T, Schulze K, Riese P, Morr M, Guzmán CA. Ebensen T, et al. Among authors: morr m. Clin Vaccine Immunol. 2007 Aug;14(8):952-8. doi: 10.1128/CVI.00119-07. Epub 2007 Jun 13. Clin Vaccine Immunol. 2007. PMID: 17567766 Free PMC article.

3

A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties.

Ebensen T, Link C, Riese P, Schulze K, Morr M, Guzmán CA. Ebensen T, et al. Among authors: morr m. J Immunol. 2007 Aug 15;179(4):2065-73. doi: 10.4049/jimmunol.179.4.2065. J Immunol. 2007. PMID: 17675464

4

The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant.

Libanova R, Ebensen T, Schulze K, Bruhn D, Nörder M, Yevsa T, Morr M, Guzmán CA. Libanova R, et al. Among authors: morr m. Vaccine. 2010 Mar 2;28(10):2249-2258. doi: 10.1016/j.vaccine.2009.12.045. Epub 2010 Jan 7. Vaccine. 2010. PMID: 20060510

5

Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.

Ebensen T, Libanova R, Schulze K, Yevsa T, Morr M, Guzmán CA. Ebensen T, et al. Among authors: morr m. Vaccine. 2011 Jul 18;29(32):5210-20. doi: 10.1016/j.vaccine.2011.05.026. Epub 2011 May 25. Vaccine. 2011. PMID: 21619907

6

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.

Rharbaoui F, Drabner B, Borsutzky S, Winckler U, Morr M, Ensoli B, Mühlradt PF, Guzmán CA. Rharbaoui F, et al. Among authors: morr m. Eur J Immunol. 2002 Oct;32(10):2857-65. doi: 10.1002/1521-4141(2002010)32:10<2857::AID-IMMU2857>3.0.CO;2-R. Eur J Immunol. 2002. PMID: 12355438 Free article.

7

Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.

Borsutzky S, Fiorelli V, Ebensen T, Tripiciano A, Rharbaoui F, Scoglio A, Link C, Nappi F, Morr M, Buttó S, Cafaro A, Mühlradt PF, Ensoli B, Guzmán CA. Borsutzky S, et al. Among authors: morr m. Eur J Immunol. 2003 Jun;33(6):1548-56. doi: 10.1002/eji.200323954. Eur J Immunol. 2003. PMID: 12778472 Free article.

8

Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate.

Meissner A, Wild V, Simm R, Rohde M, Erck C, Bredenbruch F, Morr M, Römling U, Häussler S. Meissner A, et al. Among authors: morr m. Environ Microbiol. 2007 Oct;9(10):2475-85. doi: 10.1111/j.1462-2920.2007.01366.x. Environ Microbiol. 2007. PMID: 17803773

9

Application of Synthetic Peptide Arrays To Uncover Cyclic Di-GMP Binding Motifs.

Düvel J, Bense S, Möller S, Bertinetti D, Schwede F, Morr M, Eckweiler D, Genieser HG, Jänsch L, Herberg FW, Frank R, Häussler S. Düvel J, et al. Among authors: morr m. J Bacteriol. 2015 Aug 31;198(1):138-46. doi: 10.1128/JB.00377-15. Print 2016 Jan 1. J Bacteriol. 2015. PMID: 26324453 Free PMC article.

10

A chemical proteomics approach to identify c-di-GMP binding proteins in Pseudomonas aeruginosa.

Düvel J, Bertinetti D, Möller S, Schwede F, Morr M, Wissing J, Radamm L, Zimmermann B, Genieser HG, Jänsch L, Herberg FW, Häussler S. Düvel J, et al. Among authors: morr m. J Microbiol Methods. 2012 Feb;88(2):229-36. doi: 10.1016/j.mimet.2011.11.015. Epub 2011 Dec 8. J Microbiol Methods. 2012. PMID: 22178430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters